The agreed trade sending Maxx Crosby to the Baltimore Ravens collapsed when Baltimore’s medical staff declined to clear him after he failed their physical for a meniscus injury — a decision that rested on Baltimore’s valuation of the injury relative to the extraordinary cost of two first‑round picks, not a routine failed test.
What actually fell apart
Baltimore had agreed to give the Las Vegas Raiders two first‑round picks (2026 and 2027) for Crosby. The deal was not finalized because Crosby’s knee — repaired in January 2026 after a torn meniscus that ended his 2025 season early — did not meet the Ravens’ medical standard. After the failed physical, Baltimore rescinded the offer and the picks remained with Las Vegas.
That sequence leaves Crosby on the Raiders’ roster under the extension he signed in March 2025: a three‑year, $106.5 million deal with a fully guaranteed $32.5 million salary in 2026. The extension runs through 2029 but the guarantees end after the 2026 season, which complicates both trade leverage and retention choices.
Why Baltimore walked away: risk tolerance, not a technicality
Ravens sources and their recent personnel behavior show a consistent pattern: they will cancel agreements when medical staff judge long‑term or recovery uncertainty to be worth protecting draft capital. In Crosby’s case the calculation was never just “he failed a physical”; it was whether a torn meniscus — surgically repaired in January — created a measurable chance that a player of Crosby’s age and workload profile wouldn’t justify surrendering two first‑round picks.
Put another way, Baltimore treated this as a valuation mismatch: Crosby’s upside as a game‑changing edge rusher had to outweigh the cost of two high picks plus the risk of his knee relapse or limited availability. Their threshold tipped toward preserving draft capital rather than absorbing a medical risk at that price.
Practical fallout for the Raiders (numbers and options)
The collapsed trade produces immediate roster and cap consequences because the Raiders had acted in free agency assuming Crosby would be gone. Las Vegas entered free agency with more than $120 million of cap space and signed multiple players, including former Raven center Tyler Linderbaum, anticipating the trade’s cap relief.
| Item | What was proposed / present | Immediate implication |
|---|---|---|
| Draft compensation | Ravens: 2026 & 2027 first‑round picks | Now retained by Raiders; reduces leverage for trades |
| Crosby contract | $106.5M extension through 2029; $32.5M fully guaranteed in 2026; guarantees end after 2026 | High 2026 cap hit protected; creates pressure to restructure or trade |
| Raiders’ cap posture | >$120M entering free agency; spent on several signings | Roster moves assumed trade proceeds; retaining Crosby may force restructures or reversals |
Practically, Las Vegas has three visible paths: (1) find another team willing to meet the Raiders’ original price or a slightly reduced one, (2) retain Crosby and restructure contracts to absorb the 2026 guarantee, or (3) wait until Crosby’s health is clearer and hope buyer interest returns. Each path has a clear cost: lost draft capital, increased short‑term cap strain, or delay and uncertainty.
What will change the calculus — the next checkpoints
The clearest short‑term trigger that would reopen trade talks is a medical reassessment that reduces perceived long‑term risk: documented weeks‑to‑months improvement in knee stability, cleared participation in low‑contact drills, or an independent second opinion that narrows the variance in availability projections. Without a better medical outlook, teams with conservative draft‑capital policies will demand a much lower price.
From the Raiders’ perspective, meaningful stop‑signals are also concrete: if no team meets their two‑pick asking price within the next offseason window, the realistic starting point should shift to either a one‑first‑round‑pick deal plus protections or an internal cap solution. That shift is a practical threshold for adjusting strategy rather than a judgment about Crosby’s play alone.
Quick Q&A
Q: Could Baltimore be criticized for overcaution? A: Possibly, but their record of rescinding deals over medical concerns shows they consistently prioritize draft capital preservation; that consistency explains the decision more than any single test result. Q: What’s the Raiders’ realistic best next move? A: Seek a new trade partner willing to accept downgraded compensation or prepare to restructure contracts if they choose to retain Crosby through 2026 while monitoring his recovery.
